• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Murchinson Takes Action to Replace Board of Directors of Nano Dimension at Upcoming Annual General Meeting

    8/3/23 3:00:00 PM ET
    $BWAY
    $INSG
    $MCK
    $NNDM
    Medical/Dental Instruments
    Health Care
    Telecommunications Equipment
    Telecommunications
    Get the next $BWAY alert in real time by email

    Highlights Entrenchment Tactics Taken by the Board Before and Following March Special Meeting Where Shareholders Overwhelmingly Supported Murchinson's Case for Change – Including the Removal of CEO and Chairman Yoav Stern From the Board

    Puts Forward Proposals to Improve Company's Failed Corporate Governance by Seeking to Remove All Current Directors and Appoint Five New, Experienced and Independent Nominees

    Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 5.9% of the outstanding shares of Nano Dimension Ltd., a company incorporated in Israel (NASDAQ:NNDM) ("Nano Dimension" or the "Company"), today announced that it has submitted proposals to the Company for inclusion on the agenda for the upcoming Annual General Meeting of Shareholders (the "Annual Meeting") scheduled for September 7, 2023.

    Exercising its right under Israeli law, Murchinson submitted proposals aimed at overhauling the Company's broken corporate governance, which Murchinson believes is the only pathway to improving Nano Dimension's negative enterprise value and track record of poor financial performance.

    The proposals call for:

    1. The replacement or removal of all members of the Board of Directors (the "Board"), including those who are not up for re-election at the Annual Meeting;
    2. The election or appointment of five new independent and experienced director nominees: Ms. Karen Sarid, Mr. Robert (Bob) Pons, Mr. Phillip Borenstein, Ms. Timor Arbel-Sadras, and Mr. Ofir Baharav; and
    3. Amending the Company's Articles of Association to drastically improve its governance including, among other things, the declassification of the Board.

    Murchinson stated:

    "At the Special Meeting convened by Murchinson on March 20, 2023, Nano Dimension's shareholders sent a clear message that change was urgently needed on the Company's Board. In response, Yoav Stern and Nano Dimension have taken every possible step to ignore the will of shareholders and further entrench themselves. These actions have included wasting shareholder capital by refusing to acknowledge the outcome of the vote, filing frivolous lawsuits against Murchinson and other significant investors, and waging an irrational, dead-end campaign to acquire Stratasys Ltd.

    Given that Nano Dimension has remained resolute in its desire to disenfranchise its own shareholders, we have been forced to put forth proposals to effectively replace the entire Board at the upcoming Annual Meeting. In our view, the only way to reverse the status quo of terrible governance and value destruction is to install independent directors who collectively possess the relevant 3D printing, technology, industry, operating, strategic, financial planning, M&A and governance expertise and experience. We believe that a new Board is urgently needed to protect shareholders' interests and are committed to making this a reality – regardless of any further entrenchment maneuvers taken by Nano Dimension."

    ***

    APPENDIX: MURCHINSON'S DIRECTOR CANDIDATES

    Karen Sarid brings decades of marketing, financial, operational and governance expertise, having served as a public company director and senior-level executive throughout her career.

    • Currently serves as a Director at Brainsway Ltd. (NASDAQ, TASE: BWAY), a healthcare services company, since 2017, where she serves as Chair of the Audit Committee and a member of the Compensation and Executive Committees.
    • Previously served as Vice President of Beauty and Dental and Chairman of China activities at Syneron Medical Ltd. and as President of Alma Lasers Ltd.
    • Previously awarded "CFO of the Year" by The Israeli Forum of Chief Financial Officers, which is a consortium of CFOs from Israeli corporations with annual revenue exceeding 150 million NIS.

    Robert (Bob) Pons has a lengthy track record of creating shareholder value, having served on the boards of directors of more than a dozen publicly traded companies and by bringing his experience as a turnaround specialist after more than four decades as a CEO and senior executive in high growth companies.

    • Served as President and Chief Executive Officer of Spartan Advisors, Inc., a management consulting firm specializing in telecom and technology companies, since 2017.
    • Previously served as Executive Vice President of PTGi-ICS, a wholly owned subsidiary of HC2 Holdings, Inc., a publicly traded holding company operating subsidiaries in infrastructure, telecom, construction, energy technology, gaming and life science.
    • Served on a number of public boards, including as Executive Chairman of Seachange International, Inc. (NASDAQ:SEAC) as well as a director at CCUR Holdings, Inc. (OTCPK: CCUR), Alaska Communications, Inc., Inseego Corp. (NASDAQ:INSG) and MRV Communications, Inc.

    Phillip Borenstein has significant experience creating value at companies drawing on his private equity, M&A, operational and corporate governance expertise as a senior executive and director in addition to his proficiency in financial analysis and asset management.

    • Founded and currently serves as a Partner at Hamilton EQ Management LLC, where he has managed its portfolio of commercial real estate and healthcare facilities since 2016.
    • Serves as a Director, Portfolio Manager, and Partner at Hamilton Equity Partners LLC, a private equity firm, since 2014.
    • Raised the seed money and is an active partner and supporter of the Triumph Leadership Innovation group, an organization working to empower and develop young managers.
    • Earned an M.S. degree in accounting, including research and studies relating to forensic reviews of public company financial reports.

    Timor Arbel-Sadras brings more than two decades of experience in the high-tech sector with a strong track record creating value by driving operational, investment and strategic decisions as a senior leader and director in numerous Israeli companies.

    • Currently serves as Chief Executive Officer of LeumiTech, the leading high-tech banking arm of Israel's largest bank, Bank Leumi Le Israel BM (TASE: LUMI), since 2021.
    • Previously served as a member of the Board of Directors of Negev Group Ltd., and as a board observer of various companies, including ControlUp Technologies Ltd., Earnix Ltd., and Rav Bariach Industries Ltd.
    • Led the investment decisions in Israeli technology and industrial companies while serving in various roles at Viola Credit, and previously served as Chief Operating Officer of EverC, an Israeli fintech startup.

    Ofir Baharav has a more than two-decade career as a seasoned senior executive and public company director in the technology and 3D printing sector with a focus on M&A, operational improvements, corporate governance and enhancing shareholder value.

    • Previously served as Chairman of the Nano Dimension Board from 2019 to 2021, and as a director at the Company from 2015 to 2021.
    • Currently serves as Chief Executive Officer of Maxify Solutions, Inc., since 2022, which he formed to acquire the assets of Breezer Holdings LLC and SimiGon Inc. after serving as SimiGon's CEO since 2016.
    • Served in various executive roles in the 3D printing and semiconductor sector, and was the founder of RelayHealth Corporation, a healthcare company that was acquired by McKesson Corp. (NYSE:MCK).

    ***

    About Murchinson

    Founded in 2012 and based in Toronto, Canada, Murchinson is an alternative asset management firm that serves institutional investors, family offices and qualified clients. The firm has extensive experience capturing the best returning opportunities across global markets. Murchinson's multi-strategy approach allows it to execute investments at all points in the market cycle with fluid allocation between strategies. Our team targets corporate action, distressed investing, private equity and structured finance situations, leveraging its broad market experience with a variety of specialized products and sophisticated hedging techniques to deliver alpha within a risk-averse mandate. Learn more at www.murchinsonltd.com.

    Cautionary Statement Regarding Forward-Looking Statements

    This press release contains forward-looking information within the meaning of applicable securities laws. In general, forward-looking information refers to disclosure about future conditions, courses of action, and events. All statements contained in this press release that are not clearly historical in nature or that necessarily depend on future events are forward‐looking, and the use of any of the words "anticipates", "believes", "expects", "intends", "plans", "will", "would", and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations of Murchinson and currently available information. Forward-looking statements are not guarantees of future performance, involve certain risks and uncertainties that are difficult to predict, and are based upon assumptions as to future events that may not prove to be accurate. Murchinson undertakes no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.

    Disclaimer

    The information contained or referenced herein is for information purposes only in order to provide the views of Murchinson and the matters which Murchinson believes to be of concern to shareholders described herein. The information is not tailored to specific investment objections, the financial situations, suitability, or particular need of any specific person(s) who may receive the information, and should not be taken as advice in considering the merits of any investment decision. The views expressed herein represent the views and opinions of Murchinson, whose opinions may change at any time and which are based on analyses of Murchinson and its advisors.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230802963180/en/

    Get the next $BWAY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BWAY
    $INSG
    $MCK
    $NNDM

    CompanyDatePrice TargetRatingAnalyst
    McKesson Corporation
    $MCK
    4/28/2026Outperform
    William Blair
    Inseego Corp.
    $INSG
    12/15/2025$17.00Buy
    Lake Street
    McKesson Corporation
    $MCK
    12/9/2025$960.00Overweight
    Barclays
    McKesson Corporation
    $MCK
    12/4/2024$630.00Neutral
    Mizuho
    Inseego Corp.
    $INSG
    11/14/2024$13.00 → $15.00Neutral → Buy
    ROTH MKM
    McKesson Corporation
    $MCK
    11/7/2024$531.00 → $688.00Neutral → Outperform
    Robert W. Baird
    McKesson Corporation
    $MCK
    9/24/2024$603.00 → $531.00Outperform → Neutral
    Robert W. Baird
    McKesson Corporation
    $MCK
    9/5/2024$670.00 → $665.00Outperform
    Leerink Partners
    More analyst ratings

    $BWAY
    $INSG
    $MCK
    $NNDM
    SEC Filings

    View All

    Inseego Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - INSEEGO CORP. (0001022652) (Filer)

    6/22/26 4:15:28 PM ET
    $INSG
    Telecommunications Equipment
    Telecommunications

    SEC Form 6-K filed by BrainsWay Ltd.

    6-K - Brainsway Ltd. (0001505065) (Filer)

    6/22/26 7:30:04 AM ET
    $BWAY
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by Nano Dimension Ltd.

    SCHEDULE 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    6/17/26 8:48:37 PM ET
    $NNDM
    Electrical Products
    Technology

    $BWAY
    $INSG
    $MCK
    $NNDM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on McKesson

    William Blair initiated coverage of McKesson with a rating of Outperform

    4/28/26 7:45:38 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Lake Street initiated coverage on Inseego with a new price target

    Lake Street initiated coverage of Inseego with a rating of Buy and set a new price target of $17.00

    12/15/25 8:51:06 AM ET
    $INSG
    Telecommunications Equipment
    Telecommunications

    Barclays initiated coverage on McKesson with a new price target

    Barclays initiated coverage of McKesson with a rating of Overweight and set a new price target of $960.00

    12/9/25 8:51:34 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    $BWAY
    $INSG
    $MCK
    $NNDM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Moiseyev Gilad converted options into 7,500 units of Ordinary Shares, covered exercise/tax liability with 1,902 units of Ordinary Shares and sold 5,000 units of Ordinary Shares, increasing direct ownership by 1% to 53,098 units (SEC Form 4)

    4 - Brainsway Ltd. (0001505065) (Issuer)

    6/22/26 4:04:26 PM ET
    $BWAY
    Medical/Dental Instruments
    Health Care

    Chief Executive Officer Tyler Brian S. sold $6,559,925 worth of shares (8,463 units at $775.13) as part of a pre-agreed trading plan, decreasing direct ownership by 37% to 14,382 units (SEC Form 4)

    4 - MCKESSON CORP (0000927653) (Issuer)

    6/18/26 3:35:55 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Tyler Brian S. sold $3,760,827 worth of shares (4,929 units at $763.00) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 22,845 units (SEC Form 4)

    4 - MCKESSON CORP (0000927653) (Issuer)

    6/11/26 10:30:24 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    $BWAY
    $INSG
    $MCK
    $NNDM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director North Sound Trading, Lp bought $479,504 worth of shares (55,001 units at $8.72) (SEC Form 4)

    4 - INSEEGO CORP. (0001022652) (Issuer)

    8/14/25 7:08:42 PM ET
    $INSG
    Telecommunications Equipment
    Telecommunications

    CEO Sarvikas Juho bought $97,800 worth of shares (10,000 units at $9.78), increasing direct ownership by 8% to 134,347 units (SEC Form 4)

    4 - INSEEGO CORP. (0001022652) (Issuer)

    3/5/25 4:05:10 PM ET
    $INSG
    Telecommunications Equipment
    Telecommunications

    Executive Chairman Brace Philip G bought $124,000 worth of shares (10,000 units at $12.40), increasing direct ownership by 6% to 177,763 units (SEC Form 4)

    4 - INSEEGO CORP. (0001022652) (Issuer)

    11/18/24 7:56:34 AM ET
    $INSG
    Telecommunications Equipment
    Telecommunications

    $BWAY
    $INSG
    $MCK
    $NNDM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

    McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson’s Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to he

    6/24/26 8:00:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives

    BURLINGTON, Mass. and JERUSALEM, June 22, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies, today announced further expansion in the number of medical policies across the U.S. providing favorable coverage for its SWIFT™ Accelerated Deep TMS™ protocol. The announcement comes after a series of favorable policy changes, the latest of which is a recently issued policy covering 2 million members in South Carolina allowing for coverage of SWIFT, in addition to various other increases in Deep TMS coverage for both major depressive disorder (MDD) and obsessive-compulsive disorder (OC

    6/22/26 7:30:00 AM ET
    $BWAY
    Medical/Dental Instruments
    Health Care

    Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

    WALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") and Infinite Epigenetics™ ("Infinite Epigenetics," "Infinite") today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinson's recent letter regarding the proposed transaction with Infinite. While we welcome shareholder engagement and are committed to transparency, the final details of the transaction are still being negotiated. However, we would like to address specific questions posed by Murchinson, contextualize the Infinite story and com

    6/16/26 7:43:26 PM ET
    $NNDM
    Electrical Products
    Technology

    $BWAY
    $INSG
    $MCK
    $NNDM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by BrainsWay Ltd.

    SC 13G/A - Brainsway Ltd. (0001505065) (Subject)

    11/14/24 1:33:58 PM ET
    $BWAY
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by BrainsWay Ltd.

    SC 13G/A - Brainsway Ltd. (0001505065) (Subject)

    11/14/24 1:32:48 PM ET
    $BWAY
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by BrainsWay Ltd.

    SC 13D - Brainsway Ltd. (0001505065) (Subject)

    11/13/24 6:09:51 PM ET
    $BWAY
    Medical/Dental Instruments
    Health Care

    $BWAY
    $INSG
    $MCK
    $NNDM
    Financials

    Live finance-specific insights

    View All

    McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

    McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson’s Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to he

    6/24/26 8:00:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

    Believes the Proposed Transaction Represents a Misallocation of Corporate Resources That Would Significantly Dilute Existing Shareholders Finds It Deeply Concerning That This Morning's Conference Call Offered Shareholders Little Beyond Buzzwords and Provided No Opportunity to Ask Questions Regarding a Transaction That Materially Impacts the Future of the Company Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today commented on Nano's announcement that it has signed a non-binding term

    6/15/26 5:55:00 PM ET
    $NNDM
    Electrical Products
    Technology

    Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

    Nano Dimension Conducted a Rigorous Multi-Month Strategic Review, Assessing Approximately 20 Companies Before Selecting Infinite Epigenetics as the Most Compelling Path to Long-Term Value CreationProposed Combination Would Deploy Nano Dimension's Capital Base and Nasdaq listing into a High-Growth Healthcare AI OpportunityExisting Nano Shareholders Expected to Retain Meaningful Minority Ownership in Combined Company on a Stated Value for Nano Dimension's Shares that Reflects a 20% Premium to Nano Dimension's Estimated Net Cash at ClosingInfinite Epigenetics Transaction Value of $890 million Infinite Epigenetics Targets a $90B+ U.S. Clinical Diagnostics Market Opportunity Across its Core Disea

    6/15/26 7:27:56 AM ET
    $NNDM
    Electrical Products
    Technology

    $BWAY
    $INSG
    $MCK
    $NNDM
    Leadership Updates

    Live Leadership Updates

    View All

    Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

    WALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") and Infinite Epigenetics™ ("Infinite Epigenetics," "Infinite") today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinson's recent letter regarding the proposed transaction with Infinite. While we welcome shareholder engagement and are committed to transparency, the final details of the transaction are still being negotiated. However, we would like to address specific questions posed by Murchinson, contextualize the Infinite story and com

    6/16/26 7:43:26 PM ET
    $NNDM
    Electrical Products
    Technology

    Nano Dimension Issues Letter to Shareholders

    Comments on Amended Schedule 13D Filing by Murchinson Strategic Alternatives Review Process Progresses WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) today issued the following letter to shareholders providing a business update and commenting on the Schedule 13D/A filing by Murchinson Ltd. and certain of its affiliates. The full text of the letter is below. Dear Fellow Shareholders, Nano Dimension Ltd. ("Nano" or the "Company") and its Board of Directors (the "Board") remain fully focused on executing the Company's previously announced strategic alternatives review process to maximize shareholder value and believe shareholders should understand the f

    5/26/26 8:00:00 AM ET
    $NNDM
    Electrical Products
    Technology

    Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion

    RA'ANANA, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd (NASDAQ:IINN, IINNW)) ("Inspira Technologies" or the "Company") today announced the appointment of Mr. Yoav Rozanovich as Chief Business Officer ("CBO") of Inspira Technologies, reinforcing its commercial execution capabilities following its expansion into quantum computing connectivity and the acquisition of the Additive Manufacturing of Electronics ("AME") business from Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension"). Proven Commercial LeadershipMr. Rozanovich brings international experience across additive manufacturing, advanced electronics, and complex systems integration. From November 2021

    4/14/26 8:01:00 AM ET
    $IINN
    $NNDM
    $SSYS
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology